Eli Lilly to sign $2 billion deal for AI drug development with Hong Kong's Insilico Medicine

Discover how Eli Lilly's $2 billion deal with Insilico Medicine marks a major shift in using AI to discover and commercialize new drugs for diabetes.

Level: beginner

By ET

Category: business